Ajanta Pharma LimitedNSE: AJANTPHARM

Press Release Dec 23 2025

· Issued by Ajanta Pharma Limited

Filed with NSE · · 3 pages · English

On 6ix: 6ix.com/news/press-release-dec-23-2025-2

Please find enclosed the press release titled “Ajanta signs in-licensing agreement with Biocon for marketing Semaglutide in 26 countries” We request you to take the same on your record and disseminate. The above information is also being uploaded on the website of the Company at https://www.ajantapharma.com. GAURANG SHAH Sr. VP – Legal & Company Secretary Press Release Ajanta signs in-licensing ag

Ajanta Pharma Limited on 6ix

Earlier from Ajanta Pharma

All Ajanta Pharma news releases